nodes	percent_of_prediction	percent_of_DWPC	metapath
Amisulpride—Sulpiride—CA9—hematologic cancer	0.0049	1	CrCbGaD
Amisulpride—Agranulocytosis—Methotrexate—hematologic cancer	0.000247	0.000297	CcSEcCtD
Amisulpride—Convulsion—Dexamethasone—hematologic cancer	0.000246	0.000297	CcSEcCtD
Amisulpride—Convulsion—Betamethasone—hematologic cancer	0.000246	0.000297	CcSEcCtD
Amisulpride—Headache—Thiotepa—hematologic cancer	0.000246	0.000296	CcSEcCtD
Amisulpride—Hypertension—Dexamethasone—hematologic cancer	0.000245	0.000296	CcSEcCtD
Amisulpride—Hypertension—Betamethasone—hematologic cancer	0.000245	0.000296	CcSEcCtD
Amisulpride—Diarrhoea—Ifosfamide—hematologic cancer	0.000244	0.000294	CcSEcCtD
Amisulpride—Nausea—Vinorelbine—hematologic cancer	0.000244	0.000294	CcSEcCtD
Amisulpride—Gastrointestinal disorder—Etoposide—hematologic cancer	0.000243	0.000293	CcSEcCtD
Amisulpride—Asthenia—Mitoxantrone—hematologic cancer	0.000243	0.000293	CcSEcCtD
Amisulpride—Asthenia—Irinotecan—hematologic cancer	0.000243	0.000293	CcSEcCtD
Amisulpride—Fatigue—Etoposide—hematologic cancer	0.000243	0.000293	CcSEcCtD
Amisulpride—Neuropathy peripheral—Epirubicin—hematologic cancer	0.000243	0.000292	CcSEcCtD
Amisulpride—Vomiting—Thalidomide—hematologic cancer	0.000241	0.000291	CcSEcCtD
Amisulpride—Anxiety—Betamethasone—hematologic cancer	0.000241	0.00029	CcSEcCtD
Amisulpride—Anxiety—Dexamethasone—hematologic cancer	0.000241	0.00029	CcSEcCtD
Amisulpride—Dizziness—Carmustine—hematologic cancer	0.000241	0.00029	CcSEcCtD
Amisulpride—Constipation—Etoposide—hematologic cancer	0.000241	0.00029	CcSEcCtD
Amisulpride—Neutropenia—Doxorubicin—hematologic cancer	0.00024	0.000289	CcSEcCtD
Amisulpride—Dizziness—Alitretinoin—hematologic cancer	0.000239	0.000288	CcSEcCtD
Amisulpride—Diarrhoea—Vincristine—hematologic cancer	0.000238	0.000287	CcSEcCtD
Amisulpride—Headache—Thalidomide—hematologic cancer	0.000238	0.000286	CcSEcCtD
Amisulpride—Asthenia—Gemcitabine—hematologic cancer	0.000237	0.000285	CcSEcCtD
Amisulpride—Dizziness—Ifosfamide—hematologic cancer	0.000236	0.000284	CcSEcCtD
Amisulpride—Weight increased—Doxorubicin—hematologic cancer	0.000234	0.000282	CcSEcCtD
Amisulpride—Pruritus—Gemcitabine—hematologic cancer	0.000233	0.000281	CcSEcCtD
Amisulpride—Nausea—Thiotepa—hematologic cancer	0.000233	0.000281	CcSEcCtD
Amisulpride—Weight decreased—Doxorubicin—hematologic cancer	0.000232	0.00028	CcSEcCtD
Amisulpride—Hyperglycaemia—Doxorubicin—hematologic cancer	0.000232	0.000279	CcSEcCtD
Amisulpride—Diarrhoea—Mitoxantrone—hematologic cancer	0.000232	0.000279	CcSEcCtD
Amisulpride—Diarrhoea—Irinotecan—hematologic cancer	0.000232	0.000279	CcSEcCtD
Amisulpride—Vomiting—Carmustine—hematologic cancer	0.000232	0.000279	CcSEcCtD
Amisulpride—Insomnia—Triamcinolone—hematologic cancer	0.000231	0.000278	CcSEcCtD
Amisulpride—Agranulocytosis—Epirubicin—hematologic cancer	0.000231	0.000278	CcSEcCtD
Amisulpride—Gastrointestinal pain—Etoposide—hematologic cancer	0.00023	0.000278	CcSEcCtD
Amisulpride—Dizziness—Vincristine—hematologic cancer	0.00023	0.000277	CcSEcCtD
Amisulpride—Vomiting—Alitretinoin—hematologic cancer	0.000229	0.000276	CcSEcCtD
Amisulpride—Headache—Carmustine—hematologic cancer	0.000228	0.000275	CcSEcCtD
Amisulpride—Nervous system disorder—Betamethasone—hematologic cancer	0.000227	0.000274	CcSEcCtD
Amisulpride—Nervous system disorder—Dexamethasone—hematologic cancer	0.000227	0.000274	CcSEcCtD
Amisulpride—Agitation—Prednisone—hematologic cancer	0.000227	0.000274	CcSEcCtD
Amisulpride—Vomiting—Ifosfamide—hematologic cancer	0.000227	0.000273	CcSEcCtD
Amisulpride—Hypersensitivity—Cisplatin—hematologic cancer	0.000226	0.000273	CcSEcCtD
Amisulpride—Bradycardia—Epirubicin—hematologic cancer	0.000226	0.000273	CcSEcCtD
Amisulpride—Headache—Alitretinoin—hematologic cancer	0.000226	0.000272	CcSEcCtD
Amisulpride—Angioedema—Prednisone—hematologic cancer	0.000226	0.000272	CcSEcCtD
Amisulpride—Diarrhoea—Gemcitabine—hematologic cancer	0.000226	0.000272	CcSEcCtD
Amisulpride—Nausea—Thalidomide—hematologic cancer	0.000225	0.000271	CcSEcCtD
Amisulpride—Dyspepsia—Triamcinolone—hematologic cancer	0.000225	0.000271	CcSEcCtD
Amisulpride—Neuropathy peripheral—Doxorubicin—hematologic cancer	0.000224	0.000271	CcSEcCtD
Amisulpride—Hyperhidrosis—Dexamethasone—hematologic cancer	0.000224	0.00027	CcSEcCtD
Amisulpride—Hyperhidrosis—Betamethasone—hematologic cancer	0.000224	0.00027	CcSEcCtD
Amisulpride—Dizziness—Irinotecan—hematologic cancer	0.000224	0.00027	CcSEcCtD
Amisulpride—Urticaria—Etoposide—hematologic cancer	0.000224	0.00027	CcSEcCtD
Amisulpride—Abdominal pain—Etoposide—hematologic cancer	0.000223	0.000268	CcSEcCtD
Amisulpride—Vomiting—Vincristine—hematologic cancer	0.000221	0.000266	CcSEcCtD
Amisulpride—Urticaria—Prednisolone—hematologic cancer	0.000221	0.000266	CcSEcCtD
Amisulpride—Asthenia—Cisplatin—hematologic cancer	0.000221	0.000266	CcSEcCtD
Amisulpride—Cardiac disorder—Methotrexate—hematologic cancer	0.00022	0.000266	CcSEcCtD
Amisulpride—Fatigue—Triamcinolone—hematologic cancer	0.00022	0.000265	CcSEcCtD
Amisulpride—Headache—Vincristine—hematologic cancer	0.000218	0.000263	CcSEcCtD
Amisulpride—Hypotension—Dexamethasone—hematologic cancer	0.000217	0.000261	CcSEcCtD
Amisulpride—Hypotension—Betamethasone—hematologic cancer	0.000217	0.000261	CcSEcCtD
Amisulpride—Nausea—Carmustine—hematologic cancer	0.000216	0.000261	CcSEcCtD
Amisulpride—Angiopathy—Methotrexate—hematologic cancer	0.000215	0.00026	CcSEcCtD
Amisulpride—Vomiting—Irinotecan—hematologic cancer	0.000215	0.000259	CcSEcCtD
Amisulpride—Vomiting—Mitoxantrone—hematologic cancer	0.000215	0.000259	CcSEcCtD
Amisulpride—Immune system disorder—Methotrexate—hematologic cancer	0.000214	0.000258	CcSEcCtD
Amisulpride—Nausea—Alitretinoin—hematologic cancer	0.000214	0.000258	CcSEcCtD
Amisulpride—Convulsion—Prednisone—hematologic cancer	0.000214	0.000258	CcSEcCtD
Amisulpride—Agranulocytosis—Doxorubicin—hematologic cancer	0.000214	0.000258	CcSEcCtD
Amisulpride—Hypertension—Prednisone—hematologic cancer	0.000214	0.000257	CcSEcCtD
Amisulpride—Headache—Irinotecan—hematologic cancer	0.000212	0.000256	CcSEcCtD
Amisulpride—Headache—Mitoxantrone—hematologic cancer	0.000212	0.000256	CcSEcCtD
Amisulpride—Nausea—Ifosfamide—hematologic cancer	0.000212	0.000255	CcSEcCtD
Amisulpride—Diarrhoea—Cisplatin—hematologic cancer	0.00021	0.000254	CcSEcCtD
Amisulpride—Anxiety—Prednisone—hematologic cancer	0.00021	0.000253	CcSEcCtD
Amisulpride—Vomiting—Gemcitabine—hematologic cancer	0.00021	0.000253	CcSEcCtD
Amisulpride—Insomnia—Betamethasone—hematologic cancer	0.00021	0.000253	CcSEcCtD
Amisulpride—Insomnia—Dexamethasone—hematologic cancer	0.00021	0.000253	CcSEcCtD
Amisulpride—Bradycardia—Doxorubicin—hematologic cancer	0.000209	0.000252	CcSEcCtD
Amisulpride—Unspecified disorder of skin and subcutaneous tissue—Prednisone—hematologic cancer	0.000209	0.000252	CcSEcCtD
Amisulpride—Mental disorder—Methotrexate—hematologic cancer	0.000208	0.000251	CcSEcCtD
Amisulpride—Hypersensitivity—Etoposide—hematologic cancer	0.000207	0.00025	CcSEcCtD
Amisulpride—Malnutrition—Methotrexate—hematologic cancer	0.000207	0.000249	CcSEcCtD
Amisulpride—Headache—Gemcitabine—hematologic cancer	0.000207	0.000249	CcSEcCtD
Amisulpride—Nausea—Vincristine—hematologic cancer	0.000206	0.000249	CcSEcCtD
Amisulpride—Cardiac disorder—Epirubicin—hematologic cancer	0.000206	0.000249	CcSEcCtD
Amisulpride—Hypersensitivity—Prednisolone—hematologic cancer	0.000205	0.000247	CcSEcCtD
Amisulpride—Dyspepsia—Dexamethasone—hematologic cancer	0.000204	0.000246	CcSEcCtD
Amisulpride—Dyspepsia—Betamethasone—hematologic cancer	0.000204	0.000246	CcSEcCtD
Amisulpride—Urticaria—Triamcinolone—hematologic cancer	0.000203	0.000245	CcSEcCtD
Amisulpride—Asthenia—Etoposide—hematologic cancer	0.000202	0.000244	CcSEcCtD
Amisulpride—Angiopathy—Epirubicin—hematologic cancer	0.000202	0.000243	CcSEcCtD
Amisulpride—Nausea—Mitoxantrone—hematologic cancer	0.000201	0.000242	CcSEcCtD
Amisulpride—Nausea—Irinotecan—hematologic cancer	0.000201	0.000242	CcSEcCtD
Amisulpride—Immune system disorder—Epirubicin—hematologic cancer	0.000201	0.000242	CcSEcCtD
Amisulpride—Gastrointestinal disorder—Dexamethasone—hematologic cancer	0.0002	0.000241	CcSEcCtD
Amisulpride—Gastrointestinal disorder—Betamethasone—hematologic cancer	0.0002	0.000241	CcSEcCtD
Amisulpride—Fatigue—Dexamethasone—hematologic cancer	0.0002	0.000241	CcSEcCtD
Amisulpride—Fatigue—Betamethasone—hematologic cancer	0.0002	0.000241	CcSEcCtD
Amisulpride—Pruritus—Etoposide—hematologic cancer	0.000199	0.00024	CcSEcCtD
Amisulpride—Nervous system disorder—Prednisone—hematologic cancer	0.000198	0.000239	CcSEcCtD
Amisulpride—Skin disorder—Prednisone—hematologic cancer	0.000196	0.000236	CcSEcCtD
Amisulpride—Nausea—Gemcitabine—hematologic cancer	0.000196	0.000236	CcSEcCtD
Amisulpride—Vomiting—Cisplatin—hematologic cancer	0.000195	0.000236	CcSEcCtD
Amisulpride—Hyperhidrosis—Prednisone—hematologic cancer	0.000195	0.000235	CcSEcCtD
Amisulpride—Mental disorder—Epirubicin—hematologic cancer	0.000195	0.000235	CcSEcCtD
Amisulpride—Malnutrition—Epirubicin—hematologic cancer	0.000193	0.000233	CcSEcCtD
Amisulpride—Diarrhoea—Etoposide—hematologic cancer	0.000193	0.000232	CcSEcCtD
Amisulpride—Cardiac disorder—Doxorubicin—hematologic cancer	0.000191	0.00023	CcSEcCtD
Amisulpride—Tension—Epirubicin—hematologic cancer	0.00019	0.000229	CcSEcCtD
Amisulpride—Gastrointestinal pain—Betamethasone—hematologic cancer	0.00019	0.000228	CcSEcCtD
Amisulpride—Gastrointestinal pain—Dexamethasone—hematologic cancer	0.00019	0.000228	CcSEcCtD
Amisulpride—Hypersensitivity—Triamcinolone—hematologic cancer	0.000188	0.000227	CcSEcCtD
Amisulpride—Nervousness—Epirubicin—hematologic cancer	0.000188	0.000226	CcSEcCtD
Amisulpride—Angiopathy—Doxorubicin—hematologic cancer	0.000187	0.000225	CcSEcCtD
Amisulpride—Dizziness—Etoposide—hematologic cancer	0.000186	0.000224	CcSEcCtD
Amisulpride—Muscle spasms—Epirubicin—hematologic cancer	0.000186	0.000224	CcSEcCtD
Amisulpride—Immune system disorder—Doxorubicin—hematologic cancer	0.000186	0.000224	CcSEcCtD
Amisulpride—Leukopenia—Methotrexate—hematologic cancer	0.000185	0.000223	CcSEcCtD
Amisulpride—Urticaria—Dexamethasone—hematologic cancer	0.000184	0.000222	CcSEcCtD
Amisulpride—Urticaria—Betamethasone—hematologic cancer	0.000184	0.000222	CcSEcCtD
Amisulpride—Dizziness—Prednisolone—hematologic cancer	0.000184	0.000221	CcSEcCtD
Amisulpride—Asthenia—Triamcinolone—hematologic cancer	0.000183	0.000221	CcSEcCtD
Amisulpride—Abdominal pain—Dexamethasone—hematologic cancer	0.000183	0.000221	CcSEcCtD
Amisulpride—Abdominal pain—Betamethasone—hematologic cancer	0.000183	0.000221	CcSEcCtD
Amisulpride—Nausea—Cisplatin—hematologic cancer	0.000183	0.00022	CcSEcCtD
Amisulpride—Insomnia—Prednisone—hematologic cancer	0.000183	0.00022	CcSEcCtD
Amisulpride—Pruritus—Triamcinolone—hematologic cancer	0.000181	0.000218	CcSEcCtD
Amisulpride—Mental disorder—Doxorubicin—hematologic cancer	0.00018	0.000217	CcSEcCtD
Amisulpride—Convulsion—Methotrexate—hematologic cancer	0.000179	0.000216	CcSEcCtD
Amisulpride—Vomiting—Etoposide—hematologic cancer	0.000179	0.000216	CcSEcCtD
Amisulpride—Malnutrition—Doxorubicin—hematologic cancer	0.000179	0.000216	CcSEcCtD
Amisulpride—Agitation—Epirubicin—hematologic cancer	0.000178	0.000214	CcSEcCtD
Amisulpride—Dyspepsia—Prednisone—hematologic cancer	0.000178	0.000214	CcSEcCtD
Amisulpride—Headache—Etoposide—hematologic cancer	0.000176	0.000213	CcSEcCtD
Amisulpride—Tension—Doxorubicin—hematologic cancer	0.000176	0.000212	CcSEcCtD
Amisulpride—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—hematologic cancer	0.000175	0.000211	CcSEcCtD
Amisulpride—Fatigue—Prednisone—hematologic cancer	0.000174	0.00021	CcSEcCtD
Amisulpride—Headache—Prednisolone—hematologic cancer	0.000174	0.00021	CcSEcCtD
Amisulpride—Nervousness—Doxorubicin—hematologic cancer	0.000174	0.00021	CcSEcCtD
Amisulpride—Leukopenia—Epirubicin—hematologic cancer	0.000173	0.000209	CcSEcCtD
Amisulpride—Constipation—Prednisone—hematologic cancer	0.000173	0.000208	CcSEcCtD
Amisulpride—Muscle spasms—Doxorubicin—hematologic cancer	0.000172	0.000207	CcSEcCtD
Amisulpride—Dizziness—Triamcinolone—hematologic cancer	0.000169	0.000204	CcSEcCtD
Amisulpride—Convulsion—Epirubicin—hematologic cancer	0.000168	0.000202	CcSEcCtD
Amisulpride—Nausea—Etoposide—hematologic cancer	0.000167	0.000202	CcSEcCtD
Amisulpride—Hypertension—Epirubicin—hematologic cancer	0.000167	0.000201	CcSEcCtD
Amisulpride—Asthenia—Dexamethasone—hematologic cancer	0.000166	0.0002	CcSEcCtD
Amisulpride—Asthenia—Betamethasone—hematologic cancer	0.000166	0.0002	CcSEcCtD
Amisulpride—Nervous system disorder—Methotrexate—hematologic cancer	0.000165	0.000199	CcSEcCtD
Amisulpride—Gastrointestinal pain—Prednisone—hematologic cancer	0.000165	0.000199	CcSEcCtD
Amisulpride—Nausea—Prednisolone—hematologic cancer	0.000165	0.000199	CcSEcCtD
Amisulpride—Agitation—Doxorubicin—hematologic cancer	0.000164	0.000198	CcSEcCtD
Amisulpride—Anxiety—Epirubicin—hematologic cancer	0.000164	0.000198	CcSEcCtD
Amisulpride—Pruritus—Dexamethasone—hematologic cancer	0.000164	0.000198	CcSEcCtD
Amisulpride—Pruritus—Betamethasone—hematologic cancer	0.000164	0.000198	CcSEcCtD
Amisulpride—Skin disorder—Methotrexate—hematologic cancer	0.000164	0.000197	CcSEcCtD
Amisulpride—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—hematologic cancer	0.000164	0.000197	CcSEcCtD
Amisulpride—Hyperhidrosis—Methotrexate—hematologic cancer	0.000163	0.000197	CcSEcCtD
Amisulpride—Vomiting—Triamcinolone—hematologic cancer	0.000162	0.000196	CcSEcCtD
Amisulpride—Dry mouth—Epirubicin—hematologic cancer	0.000161	0.000194	CcSEcCtD
Amisulpride—Urticaria—Prednisone—hematologic cancer	0.00016	0.000193	CcSEcCtD
Amisulpride—Leukopenia—Doxorubicin—hematologic cancer	0.00016	0.000193	CcSEcCtD
Amisulpride—Headache—Triamcinolone—hematologic cancer	0.00016	0.000193	CcSEcCtD
Amisulpride—Abdominal pain—Prednisone—hematologic cancer	0.00016	0.000192	CcSEcCtD
Amisulpride—Diarrhoea—Betamethasone—hematologic cancer	0.000159	0.000191	CcSEcCtD
Amisulpride—Diarrhoea—Dexamethasone—hematologic cancer	0.000159	0.000191	CcSEcCtD
Amisulpride—Hypotension—Methotrexate—hematologic cancer	0.000158	0.00019	CcSEcCtD
Amisulpride—Convulsion—Doxorubicin—hematologic cancer	0.000155	0.000187	CcSEcCtD
Amisulpride—Nervous system disorder—Epirubicin—hematologic cancer	0.000155	0.000187	CcSEcCtD
Amisulpride—Hypertension—Doxorubicin—hematologic cancer	0.000155	0.000186	CcSEcCtD
Amisulpride—Skin disorder—Epirubicin—hematologic cancer	0.000153	0.000185	CcSEcCtD
Amisulpride—Dizziness—Dexamethasone—hematologic cancer	0.000153	0.000185	CcSEcCtD
Amisulpride—Dizziness—Betamethasone—hematologic cancer	0.000153	0.000185	CcSEcCtD
Amisulpride—Hyperhidrosis—Epirubicin—hematologic cancer	0.000153	0.000184	CcSEcCtD
Amisulpride—Insomnia—Methotrexate—hematologic cancer	0.000153	0.000184	CcSEcCtD
Amisulpride—Anxiety—Doxorubicin—hematologic cancer	0.000152	0.000183	CcSEcCtD
Amisulpride—Nausea—Triamcinolone—hematologic cancer	0.000152	0.000183	CcSEcCtD
Amisulpride—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—hematologic cancer	0.000151	0.000182	CcSEcCtD
Amisulpride—Somnolence—Methotrexate—hematologic cancer	0.00015	0.000181	CcSEcCtD
Amisulpride—Dry mouth—Doxorubicin—hematologic cancer	0.000149	0.00018	CcSEcCtD
Amisulpride—Hypersensitivity—Prednisone—hematologic cancer	0.000149	0.000179	CcSEcCtD
Amisulpride—Dyspepsia—Methotrexate—hematologic cancer	0.000148	0.000179	CcSEcCtD
Amisulpride—Hypotension—Epirubicin—hematologic cancer	0.000148	0.000178	CcSEcCtD
Amisulpride—Vomiting—Betamethasone—hematologic cancer	0.000147	0.000178	CcSEcCtD
Amisulpride—Vomiting—Dexamethasone—hematologic cancer	0.000147	0.000178	CcSEcCtD
Amisulpride—Gastrointestinal disorder—Methotrexate—hematologic cancer	0.000146	0.000176	CcSEcCtD
Amisulpride—Fatigue—Methotrexate—hematologic cancer	0.000145	0.000175	CcSEcCtD
Amisulpride—Headache—Dexamethasone—hematologic cancer	0.000145	0.000175	CcSEcCtD
Amisulpride—Headache—Betamethasone—hematologic cancer	0.000145	0.000175	CcSEcCtD
Amisulpride—Asthenia—Prednisone—hematologic cancer	0.000145	0.000175	CcSEcCtD
Amisulpride—Nervous system disorder—Doxorubicin—hematologic cancer	0.000143	0.000173	CcSEcCtD
Amisulpride—Pruritus—Prednisone—hematologic cancer	0.000143	0.000172	CcSEcCtD
Amisulpride—Insomnia—Epirubicin—hematologic cancer	0.000143	0.000172	CcSEcCtD
Amisulpride—Skin disorder—Doxorubicin—hematologic cancer	0.000142	0.000171	CcSEcCtD
Amisulpride—Hyperhidrosis—Doxorubicin—hematologic cancer	0.000141	0.00017	CcSEcCtD
Amisulpride—Somnolence—Epirubicin—hematologic cancer	0.00014	0.000169	CcSEcCtD
Amisulpride—Dyspepsia—Epirubicin—hematologic cancer	0.000139	0.000167	CcSEcCtD
Amisulpride—Diarrhoea—Prednisone—hematologic cancer	0.000138	0.000166	CcSEcCtD
Amisulpride—Gastrointestinal pain—Methotrexate—hematologic cancer	0.000138	0.000166	CcSEcCtD
Amisulpride—Nausea—Dexamethasone—hematologic cancer	0.000138	0.000166	CcSEcCtD
Amisulpride—Nausea—Betamethasone—hematologic cancer	0.000138	0.000166	CcSEcCtD
Amisulpride—Hypotension—Doxorubicin—hematologic cancer	0.000136	0.000165	CcSEcCtD
Amisulpride—Gastrointestinal disorder—Epirubicin—hematologic cancer	0.000136	0.000164	CcSEcCtD
Amisulpride—Fatigue—Epirubicin—hematologic cancer	0.000136	0.000164	CcSEcCtD
Amisulpride—Constipation—Epirubicin—hematologic cancer	0.000135	0.000163	CcSEcCtD
Amisulpride—Urticaria—Methotrexate—hematologic cancer	0.000134	0.000162	CcSEcCtD
Amisulpride—Dizziness—Prednisone—hematologic cancer	0.000133	0.000161	CcSEcCtD
Amisulpride—Abdominal pain—Methotrexate—hematologic cancer	0.000133	0.000161	CcSEcCtD
Amisulpride—Insomnia—Doxorubicin—hematologic cancer	0.000132	0.000159	CcSEcCtD
Amisulpride—Somnolence—Doxorubicin—hematologic cancer	0.00013	0.000157	CcSEcCtD
Amisulpride—Gastrointestinal pain—Epirubicin—hematologic cancer	0.000129	0.000156	CcSEcCtD
Amisulpride—Dyspepsia—Doxorubicin—hematologic cancer	0.000129	0.000155	CcSEcCtD
Amisulpride—Vomiting—Prednisone—hematologic cancer	0.000128	0.000155	CcSEcCtD
Amisulpride—Headache—Prednisone—hematologic cancer	0.000126	0.000152	CcSEcCtD
Amisulpride—Gastrointestinal disorder—Doxorubicin—hematologic cancer	0.000126	0.000152	CcSEcCtD
Amisulpride—Fatigue—Doxorubicin—hematologic cancer	0.000126	0.000152	CcSEcCtD
Amisulpride—Urticaria—Epirubicin—hematologic cancer	0.000125	0.000151	CcSEcCtD
Amisulpride—Constipation—Doxorubicin—hematologic cancer	0.000125	0.000151	CcSEcCtD
Amisulpride—Abdominal pain—Epirubicin—hematologic cancer	0.000125	0.00015	CcSEcCtD
Amisulpride—Hypersensitivity—Methotrexate—hematologic cancer	0.000124	0.00015	CcSEcCtD
Amisulpride—Asthenia—Methotrexate—hematologic cancer	0.000121	0.000146	CcSEcCtD
Amisulpride—Nausea—Prednisone—hematologic cancer	0.00012	0.000145	CcSEcCtD
Amisulpride—Gastrointestinal pain—Doxorubicin—hematologic cancer	0.000119	0.000144	CcSEcCtD
Amisulpride—Pruritus—Methotrexate—hematologic cancer	0.000119	0.000144	CcSEcCtD
Amisulpride—Hypersensitivity—Epirubicin—hematologic cancer	0.000116	0.00014	CcSEcCtD
Amisulpride—Urticaria—Doxorubicin—hematologic cancer	0.000116	0.00014	CcSEcCtD
Amisulpride—Abdominal pain—Doxorubicin—hematologic cancer	0.000115	0.000139	CcSEcCtD
Amisulpride—Diarrhoea—Methotrexate—hematologic cancer	0.000115	0.000139	CcSEcCtD
Amisulpride—Asthenia—Epirubicin—hematologic cancer	0.000113	0.000137	CcSEcCtD
Amisulpride—Pruritus—Epirubicin—hematologic cancer	0.000112	0.000135	CcSEcCtD
Amisulpride—Dizziness—Methotrexate—hematologic cancer	0.000112	0.000134	CcSEcCtD
Amisulpride—Diarrhoea—Epirubicin—hematologic cancer	0.000108	0.00013	CcSEcCtD
Amisulpride—Hypersensitivity—Doxorubicin—hematologic cancer	0.000108	0.00013	CcSEcCtD
Amisulpride—Vomiting—Methotrexate—hematologic cancer	0.000107	0.000129	CcSEcCtD
Amisulpride—Headache—Methotrexate—hematologic cancer	0.000106	0.000127	CcSEcCtD
Amisulpride—Asthenia—Doxorubicin—hematologic cancer	0.000105	0.000126	CcSEcCtD
Amisulpride—Dizziness—Epirubicin—hematologic cancer	0.000104	0.000126	CcSEcCtD
Amisulpride—Pruritus—Doxorubicin—hematologic cancer	0.000103	0.000125	CcSEcCtD
Amisulpride—Vomiting—Epirubicin—hematologic cancer	0.0001	0.000121	CcSEcCtD
Amisulpride—Nausea—Methotrexate—hematologic cancer	0.0001	0.000121	CcSEcCtD
Amisulpride—Diarrhoea—Doxorubicin—hematologic cancer	9.99e-05	0.00012	CcSEcCtD
Amisulpride—Headache—Epirubicin—hematologic cancer	9.89e-05	0.000119	CcSEcCtD
Amisulpride—Dizziness—Doxorubicin—hematologic cancer	9.66e-05	0.000116	CcSEcCtD
Amisulpride—Nausea—Epirubicin—hematologic cancer	9.38e-05	0.000113	CcSEcCtD
Amisulpride—Vomiting—Doxorubicin—hematologic cancer	9.29e-05	0.000112	CcSEcCtD
Amisulpride—Headache—Doxorubicin—hematologic cancer	9.15e-05	0.00011	CcSEcCtD
Amisulpride—Nausea—Doxorubicin—hematologic cancer	8.68e-05	0.000105	CcSEcCtD
Amisulpride—DRD3—Signaling Pathways—PIK3CG—hematologic cancer	2.36e-05	0.000143	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—KIT—hematologic cancer	2.36e-05	0.000143	CbGpPWpGaD
Amisulpride—DRD3—Signaling by GPCR—NRAS—hematologic cancer	2.36e-05	0.000143	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—IL6R—hematologic cancer	2.36e-05	0.000143	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—CREBBP—hematologic cancer	2.36e-05	0.000142	CbGpPWpGaD
Amisulpride—DRD2—Signaling by GPCR—PIK3CB—hematologic cancer	2.35e-05	0.000142	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—FGF2—hematologic cancer	2.34e-05	0.000141	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—FOXO1—hematologic cancer	2.34e-05	0.000141	CbGpPWpGaD
Amisulpride—HTR2A—GPCR downstream signaling—IL2—hematologic cancer	2.34e-05	0.000141	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—PDGFRA—hematologic cancer	2.33e-05	0.000141	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—PDGFRB—hematologic cancer	2.33e-05	0.000141	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—PRKCG—hematologic cancer	2.33e-05	0.000141	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—JAK1—hematologic cancer	2.33e-05	0.000141	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—PTPN11—hematologic cancer	2.32e-05	0.00014	CbGpPWpGaD
Amisulpride—HTR2A—Signaling by GPCR—PIK3CB—hematologic cancer	2.31e-05	0.00014	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—PIK3R1—hematologic cancer	2.31e-05	0.000139	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—PDGFRA—hematologic cancer	2.3e-05	0.000139	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—PRKCG—hematologic cancer	2.29e-05	0.000138	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—JAK1—hematologic cancer	2.29e-05	0.000138	CbGpPWpGaD
Amisulpride—DRD3—Signaling by GPCR—MAPK3—hematologic cancer	2.26e-05	0.000137	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—CREB1—hematologic cancer	2.25e-05	0.000136	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—MAP2K1—hematologic cancer	2.25e-05	0.000136	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—JAK2—hematologic cancer	2.24e-05	0.000136	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—PIK3CD—hematologic cancer	2.23e-05	0.000135	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—BRAF—hematologic cancer	2.22e-05	0.000134	CbGpPWpGaD
Amisulpride—HTR2B—GPCR downstream signaling—PIK3CA—hematologic cancer	2.21e-05	0.000134	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—CCL2—hematologic cancer	2.2e-05	0.000133	CbGpPWpGaD
Amisulpride—HTR7—Signaling by GPCR—PIK3CA—hematologic cancer	2.2e-05	0.000133	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—IL6R—hematologic cancer	2.2e-05	0.000133	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—CREBBP—hematologic cancer	2.19e-05	0.000132	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—MDM2—hematologic cancer	2.19e-05	0.000132	CbGpPWpGaD
Amisulpride—HTR2B—Signaling by GPCR—KRAS—hematologic cancer	2.19e-05	0.000132	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—IL2RA—hematologic cancer	2.17e-05	0.000131	CbGpPWpGaD
Amisulpride—DRD2—Signaling by GPCR—IL2—hematologic cancer	2.16e-05	0.00013	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—TERT—hematologic cancer	2.15e-05	0.00013	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—FGF2—hematologic cancer	2.14e-05	0.000129	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—IL2RA—hematologic cancer	2.14e-05	0.000129	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—MTOR—hematologic cancer	2.13e-05	0.000129	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—PIK3CB—hematologic cancer	2.13e-05	0.000129	CbGpPWpGaD
Amisulpride—HTR2A—Signaling by GPCR—IL2—hematologic cancer	2.12e-05	0.000128	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—TERT—hematologic cancer	2.11e-05	0.000128	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—PIK3R1—hematologic cancer	2.11e-05	0.000127	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—PDGFB—hematologic cancer	2.1e-05	0.000127	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—MAP2K1—hematologic cancer	2.09e-05	0.000126	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—PIK3CD—hematologic cancer	2.08e-05	0.000126	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—PDGFB—hematologic cancer	2.06e-05	0.000125	CbGpPWpGaD
Amisulpride—DRD3—GPCR downstream signaling—PIK3CA—hematologic cancer	2.06e-05	0.000124	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—JAK2—hematologic cancer	2.05e-05	0.000124	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—TSC2—hematologic cancer	2.05e-05	0.000124	CbGpPWpGaD
Amisulpride—DRD3—Signaling by GPCR—KRAS—hematologic cancer	2.03e-05	0.000123	CbGpPWpGaD
Amisulpride—HTR7—Signaling by GPCR—HRAS—hematologic cancer	2.03e-05	0.000123	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—TSC2—hematologic cancer	2.02e-05	0.000122	CbGpPWpGaD
Amisulpride—HTR2B—Signaling by GPCR—PIK3CA—hematologic cancer	2.01e-05	0.000121	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—MDM2—hematologic cancer	2e-05	0.000121	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—CDKN1B—hematologic cancer	2e-05	0.000121	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—FGF2—hematologic cancer	1.99e-05	0.00012	CbGpPWpGaD
Amisulpride—HTR7—GPCR downstream signaling—AKT1—hematologic cancer	1.98e-05	0.00012	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—FGFR3—hematologic cancer	1.97e-05	0.000119	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—PIK3R1—hematologic cancer	1.96e-05	0.000119	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—CASP3—hematologic cancer	1.96e-05	0.000118	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—IL2—hematologic cancer	1.96e-05	0.000118	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—MAPK14—hematologic cancer	1.95e-05	0.000118	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—MTOR—hematologic cancer	1.95e-05	0.000118	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—PIK3CB—hematologic cancer	1.95e-05	0.000118	CbGpPWpGaD
Amisulpride—HTR7—Signaling by GPCR—IL6—hematologic cancer	1.95e-05	0.000118	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—FGFR3—hematologic cancer	1.94e-05	0.000117	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—MAPK14—hematologic cancer	1.92e-05	0.000116	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—ESR1—hematologic cancer	1.91e-05	0.000116	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—JAK2—hematologic cancer	1.91e-05	0.000115	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—CCND1—hematologic cancer	1.91e-05	0.000115	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—JUN—hematologic cancer	1.9e-05	0.000115	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—FN1—hematologic cancer	1.89e-05	0.000114	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—ESR1—hematologic cancer	1.88e-05	0.000114	CbGpPWpGaD
Amisulpride—DRD3—Signaling by GPCR—PIK3CA—hematologic cancer	1.87e-05	0.000113	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—BAD—hematologic cancer	1.87e-05	0.000113	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—NFKBIA—hematologic cancer	1.87e-05	0.000113	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—MDM2—hematologic cancer	1.86e-05	0.000113	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—FN1—hematologic cancer	1.86e-05	0.000112	CbGpPWpGaD
Amisulpride—HTR2B—Signaling by GPCR—HRAS—hematologic cancer	1.86e-05	0.000112	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—NOTCH1—hematologic cancer	1.85e-05	0.000112	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—CDKN1A—hematologic cancer	1.85e-05	0.000111	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—PTEN—hematologic cancer	1.84e-05	0.000111	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—NFKBIA—hematologic cancer	1.84e-05	0.000111	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—BAD—hematologic cancer	1.84e-05	0.000111	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—CDKN1B—hematologic cancer	1.83e-05	0.00011	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—NOTCH1—hematologic cancer	1.82e-05	0.00011	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—CD80—hematologic cancer	1.81e-05	0.00011	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—PIK3CB—hematologic cancer	1.81e-05	0.000109	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—MTOR—hematologic cancer	1.81e-05	0.000109	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—PIK3CG—hematologic cancer	1.81e-05	0.000109	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—KIT—hematologic cancer	1.81e-05	0.000109	CbGpPWpGaD
Amisulpride—DRD2—Signaling by GPCR—NRAS—hematologic cancer	1.81e-05	0.000109	CbGpPWpGaD
Amisulpride—HTR2B—GPCR downstream signaling—AKT1—hematologic cancer	1.81e-05	0.000109	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—MAPK8—hematologic cancer	1.8e-05	0.000109	CbGpPWpGaD
Amisulpride—HTR7—Signaling by GPCR—AKT1—hematologic cancer	1.8e-05	0.000109	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—CASP3—hematologic cancer	1.79e-05	0.000108	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—IL2—hematologic cancer	1.79e-05	0.000108	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—CD80—hematologic cancer	1.78e-05	0.000108	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—KIT—hematologic cancer	1.78e-05	0.000108	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—PIK3CG—hematologic cancer	1.78e-05	0.000108	CbGpPWpGaD
Amisulpride—HTR2A—Signaling by GPCR—NRAS—hematologic cancer	1.78e-05	0.000108	CbGpPWpGaD
Amisulpride—HTR2B—Signaling by GPCR—IL6—hematologic cancer	1.78e-05	0.000107	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—PTPN11—hematologic cancer	1.78e-05	0.000107	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—EP300—hematologic cancer	1.76e-05	0.000106	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—PTPN11—hematologic cancer	1.75e-05	0.000106	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—CCND1—hematologic cancer	1.74e-05	0.000105	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—JUN—hematologic cancer	1.74e-05	0.000105	CbGpPWpGaD
Amisulpride—DRD2—Signaling by GPCR—MAPK3—hematologic cancer	1.73e-05	0.000105	CbGpPWpGaD
Amisulpride—DRD3—Signaling by GPCR—HRAS—hematologic cancer	1.73e-05	0.000105	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—CREB1—hematologic cancer	1.72e-05	0.000104	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—SRC—hematologic cancer	1.71e-05	0.000103	CbGpPWpGaD
Amisulpride—HTR2A—Signaling by GPCR—MAPK3—hematologic cancer	1.7e-05	0.000103	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—BRAF—hematologic cancer	1.7e-05	0.000103	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—CDKN1B—hematologic cancer	1.7e-05	0.000103	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—CREB1—hematologic cancer	1.69e-05	0.000102	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—CDKN1A—hematologic cancer	1.69e-05	0.000102	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—CCL2—hematologic cancer	1.68e-05	0.000102	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—PTEN—hematologic cancer	1.68e-05	0.000102	CbGpPWpGaD
Amisulpride—DRD3—GPCR downstream signaling—AKT1—hematologic cancer	1.68e-05	0.000102	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—IL6R—hematologic cancer	1.68e-05	0.000102	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—CREBBP—hematologic cancer	1.68e-05	0.000101	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—BRAF—hematologic cancer	1.67e-05	0.000101	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—CASP3—hematologic cancer	1.67e-05	0.000101	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—IL2—hematologic cancer	1.66e-05	0.000101	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—VEGFA—hematologic cancer	1.66e-05	0.0001	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—CCL2—hematologic cancer	1.66e-05	0.0001	CbGpPWpGaD
Amisulpride—DRD3—Signaling by GPCR—IL6—hematologic cancer	1.66e-05	0.0001	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—IL6R—hematologic cancer	1.65e-05	9.99e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—CREBBP—hematologic cancer	1.65e-05	9.97e-05	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—STAT3—hematologic cancer	1.65e-05	9.95e-05	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—MAPK8—hematologic cancer	1.65e-05	9.94e-05	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—NRAS—hematologic cancer	1.64e-05	9.92e-05	CbGpPWpGaD
Amisulpride—HTR2B—Signaling by GPCR—AKT1—hematologic cancer	1.64e-05	9.92e-05	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—CCND1—hematologic cancer	1.62e-05	9.8e-05	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—JUN—hematologic cancer	1.62e-05	9.78e-05	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—EP300—hematologic cancer	1.6e-05	9.69e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—MAP2K1—hematologic cancer	1.6e-05	9.67e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—PIK3CD—hematologic cancer	1.59e-05	9.61e-05	CbGpPWpGaD
Amisulpride—DRD2—GPCR downstream signaling—PIK3CA—hematologic cancer	1.58e-05	9.52e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—MAP2K1—hematologic cancer	1.58e-05	9.52e-05	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—MAPK3—hematologic cancer	1.57e-05	9.51e-05	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—CDKN1A—hematologic cancer	1.57e-05	9.48e-05	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—PTEN—hematologic cancer	1.57e-05	9.46e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—PIK3CD—hematologic cancer	1.56e-05	9.46e-05	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—SRC—hematologic cancer	1.56e-05	9.43e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling by GPCR—KRAS—hematologic cancer	1.56e-05	9.41e-05	CbGpPWpGaD
Amisulpride—HTR2A—GPCR downstream signaling—PIK3CA—hematologic cancer	1.55e-05	9.37e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling by GPCR—KRAS—hematologic cancer	1.53e-05	9.26e-05	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—MAPK8—hematologic cancer	1.53e-05	9.25e-05	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—MYC—hematologic cancer	1.53e-05	9.24e-05	CbGpPWpGaD
Amisulpride—DRD3—Signaling by GPCR—AKT1—hematologic cancer	1.53e-05	9.23e-05	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—TGFB1—hematologic cancer	1.53e-05	9.22e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—FGF2—hematologic cancer	1.52e-05	9.2e-05	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—VEGFA—hematologic cancer	1.52e-05	9.18e-05	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—STAT3—hematologic cancer	1.5e-05	9.09e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—PIK3R1—hematologic cancer	1.5e-05	9.07e-05	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—NRAS—hematologic cancer	1.5e-05	9.07e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—FGF2—hematologic cancer	1.5e-05	9.05e-05	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—EP300—hematologic cancer	1.49e-05	9.02e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—PIK3R1—hematologic cancer	1.48e-05	8.93e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—JAK2—hematologic cancer	1.46e-05	8.82e-05	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—SRC—hematologic cancer	1.45e-05	8.77e-05	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—MAPK3—hematologic cancer	1.44e-05	8.69e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—JAK2—hematologic cancer	1.44e-05	8.68e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling by GPCR—PIK3CA—hematologic cancer	1.43e-05	8.64e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—MDM2—hematologic cancer	1.42e-05	8.61e-05	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—VEGFA—hematologic cancer	1.41e-05	8.54e-05	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—KRAS—hematologic cancer	1.41e-05	8.54e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling by GPCR—PIK3CA—hematologic cancer	1.41e-05	8.5e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—MDM2—hematologic cancer	1.4e-05	8.47e-05	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—STAT3—hematologic cancer	1.4e-05	8.46e-05	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—MYC—hematologic cancer	1.4e-05	8.45e-05	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—NRAS—hematologic cancer	1.4e-05	8.44e-05	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—TGFB1—hematologic cancer	1.39e-05	8.43e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—PIK3CB—hematologic cancer	1.39e-05	8.38e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—MTOR—hematologic cancer	1.39e-05	8.38e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—MTOR—hematologic cancer	1.36e-05	8.24e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—PIK3CB—hematologic cancer	1.36e-05	8.24e-05	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—MAPK3—hematologic cancer	1.34e-05	8.08e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling by GPCR—HRAS—hematologic cancer	1.32e-05	8e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling by GPCR—HRAS—hematologic cancer	1.3e-05	7.87e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—CDKN1B—hematologic cancer	1.3e-05	7.86e-05	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—MYC—hematologic cancer	1.3e-05	7.86e-05	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—PIK3CA—hematologic cancer	1.3e-05	7.85e-05	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—TGFB1—hematologic cancer	1.3e-05	7.84e-05	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—KRAS—hematologic cancer	1.29e-05	7.81e-05	CbGpPWpGaD
Amisulpride—DRD2—GPCR downstream signaling—AKT1—hematologic cancer	1.29e-05	7.78e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—CDKN1B—hematologic cancer	1.28e-05	7.73e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—CASP3—hematologic cancer	1.27e-05	7.7e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—IL2—hematologic cancer	1.27e-05	7.69e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling by GPCR—IL6—hematologic cancer	1.27e-05	7.65e-05	CbGpPWpGaD
Amisulpride—HTR2A—GPCR downstream signaling—AKT1—hematologic cancer	1.27e-05	7.65e-05	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—TP53—hematologic cancer	1.26e-05	7.59e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—CASP3—hematologic cancer	1.25e-05	7.58e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—IL2—hematologic cancer	1.25e-05	7.57e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling by GPCR—IL6—hematologic cancer	1.25e-05	7.53e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—CCND1—hematologic cancer	1.24e-05	7.5e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—JUN—hematologic cancer	1.24e-05	7.48e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—CCND1—hematologic cancer	1.22e-05	7.38e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—JUN—hematologic cancer	1.22e-05	7.36e-05	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—KRAS—hematologic cancer	1.2e-05	7.26e-05	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—HRAS—hematologic cancer	1.2e-05	7.26e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—CDKN1A—hematologic cancer	1.2e-05	7.25e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—PTEN—hematologic cancer	1.2e-05	7.24e-05	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—PIK3CA—hematologic cancer	1.19e-05	7.17e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—CDKN1A—hematologic cancer	1.18e-05	7.14e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—PTEN—hematologic cancer	1.18e-05	7.12e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—MAPK8—hematologic cancer	1.17e-05	7.08e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling by GPCR—AKT1—hematologic cancer	1.17e-05	7.06e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—MAPK8—hematologic cancer	1.15e-05	6.97e-05	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—IL6—hematologic cancer	1.15e-05	6.95e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling by GPCR—AKT1—hematologic cancer	1.15e-05	6.95e-05	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—TP53—hematologic cancer	1.15e-05	6.94e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—EP300—hematologic cancer	1.14e-05	6.9e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—EP300—hematologic cancer	1.12e-05	6.79e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—SRC—hematologic cancer	1.11e-05	6.71e-05	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—PIK3CA—hematologic cancer	1.1e-05	6.67e-05	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—HRAS—hematologic cancer	1.1e-05	6.63e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—SRC—hematologic cancer	1.09e-05	6.6e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—VEGFA—hematologic cancer	1.08e-05	6.54e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—STAT3—hematologic cancer	1.07e-05	6.47e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—NRAS—hematologic cancer	1.07e-05	6.46e-05	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—TP53—hematologic cancer	1.07e-05	6.46e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—VEGFA—hematologic cancer	1.06e-05	6.43e-05	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—AKT1—hematologic cancer	1.06e-05	6.41e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—STAT3—hematologic cancer	1.05e-05	6.37e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—NRAS—hematologic cancer	1.05e-05	6.35e-05	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—IL6—hematologic cancer	1.05e-05	6.35e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—MAPK3—hematologic cancer	1.02e-05	6.18e-05	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—HRAS—hematologic cancer	1.02e-05	6.17e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—MAPK3—hematologic cancer	1.01e-05	6.09e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—MYC—hematologic cancer	9.95e-06	6.01e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—TGFB1—hematologic cancer	9.93e-06	6e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—MYC—hematologic cancer	9.79e-06	5.92e-05	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—IL6—hematologic cancer	9.78e-06	5.91e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—TGFB1—hematologic cancer	9.77e-06	5.9e-05	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—AKT1—hematologic cancer	9.7e-06	5.86e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—KRAS—hematologic cancer	9.2e-06	5.56e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—KRAS—hematologic cancer	9.05e-06	5.47e-05	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—AKT1—hematologic cancer	9.02e-06	5.45e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—PIK3CA—hematologic cancer	8.45e-06	5.11e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—PIK3CA—hematologic cancer	8.31e-06	5.02e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—TP53—hematologic cancer	8.17e-06	4.94e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—TP53—hematologic cancer	8.04e-06	4.86e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—HRAS—hematologic cancer	7.82e-06	4.72e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—HRAS—hematologic cancer	7.69e-06	4.65e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—IL6—hematologic cancer	7.48e-06	4.52e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—IL6—hematologic cancer	7.36e-06	4.45e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—AKT1—hematologic cancer	6.9e-06	4.17e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—AKT1—hematologic cancer	6.79e-06	4.1e-05	CbGpPWpGaD
